Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Industry News

    Funding Award for a Combined Smallpox-Marburg Vaccine

    By Global Biodefense StaffJune 20, 2012
    Share
    Facebook LinkedIn Reddit Email

    Danish drug maker Bavarian Nordic this week announced an award from the U.S. government, valued at up $18 million over 5-years, to advance development of a combined vaccine against smallpox and Marburg virus.

    Issued by the National Institute of Allergy and Infectious Diseases (NIAID), the contract supports furthering candidate vaccine components and technologies that accelerate the immune response for use in post-event settings following the intentional release of pathogens that are considered a threat to public health.

    Under the 2 year base period of the contract, valued at $4.4 million, the company will evaluate several candidate vaccines in preclinical studies. This may be followed by a Phase I clinical trial if NIAID extends contract options for the full five years.

    Bavarian Nordic delivered four million doses of their IMVAMUNE® smallpox vaccines to the U.S. government in 2011 and anticipates delivery of approximately 14 million doses of IMVAMUNE® in 2012 through 2013 (Source: Bavarian Nordic 2011 Annual Report). The company additionally received a contract in April 2011 for development of a freeze-dried version of their smallpox vaccine to a total value of $94 million.

    Awards Marburg Poxviruses Smallpox Vaccine News
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleEmergent Biosolutions, Novartis, Texas A&M to Lead New Biodefense Centers
    Next Article NanoLogix Improves Live-Cell Detection Times for Biothreat Agents

    Related Stories

    Jurata Thin Film and CastleVax Awarded Grant to Advance Thermostabilized COVID-19 Booster

    September 20, 2023

    Mount Sinai to Lead Development of Pan-Coronavirus Vaccine Under New Federal Grant

    September 17, 2023

    NIAID Seeks to Improve Computational Models of Influenza Immunity

    September 15, 2023

    Smallpox Vaccines: Bavarian Nordic Awarded Another Contract to Supply EU Strategic Reserve

    September 13, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy